REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
18/08/2025
Voltar para busca
Dado oficial do USPTO
NT NOVOTECH THE ASIA PACIFIC CRO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
19/08/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42
Data de depósito
22/11/2019
Data de registro
18/08/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/08/2020
Última transação
19/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
AU
Examinador
BLAZICH,JOAN MICHELE
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "NT NOVOTECH" above "THE ASIA PACIFIC CRO", all in stylized font.
Titulares e representantes
Titulares
Novotech (Australia) Pty Ltd
Representantes
Eleanor M. Yost Carlton Fields, PA
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Conducting clinical trials for others; conducting and managing clinical trials in the nature of conducting clinical trials for others in the field of pharmaceuticalsbiotechnology and other related industries; conducting clinical trials for others scientific research; providing medical and scientific research information about the results of clinical trialsincluding clinical trials for pharmaceuticals and biotechnology; scientific research; scientific research for medical purposes in the field of pharmaceuticalsbiotechnologyrelated industries; preparation of statisticsscientific analysis in the field of clinical trial results for scientific research; preparation of biostatisticsscientific analysis in the field of clinical trial results for scientific research in the fields of pharmaceuticalsbiotechnology and other related industries; provision of medical and scientific research information and data relating to medical and scientific research for pharmaceuticalsbiotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research servicesmedical monitoring services for research in the fields of pharmaceuticalsbiotechnology and other related industries; quality auditsinspection for quality control purposes and quality control for otherstechnology supervision and technical verification of clinical trial designs and clinical trial data; preparation of reports and applications to regulators relating to aspects of clinical trialsproviding medical research and scientific information and data in the field of clinical trials; provision and exchange of information and data exchange between scientistsmanufacturers and health authorities relating to pharmaceutical and biotechnology quality standardsproviding a website featuring technology enabling authorized users to generatemanageexchange medical and scientific informationdata and documents; technical writing of clinical report forms which are required by clinical trial drug protocols
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/12/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/12/2020
FIMP
FINAL DISPOSITION PROCESSED
07/12/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/11/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
18/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2020
PUBO
PUBLISHED FOR OPPOSITION
02/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/05/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/04/2020
ALIE
ASSIGNED TO LIE
28/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/04/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
22/04/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/04/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
22/04/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/04/2020
RFNT
REFUSAL PROCESSED BY IB
10/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/04/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/03/2020
RFRR
REFUSAL PROCESSED BY MPU
19/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/03/2020
CNRT
NON-FINAL ACTION WRITTEN
02/03/2020
DOCK
ASSIGNED TO EXAMINER
26/02/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2020
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
19/12/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NT NOVOTECH THE ASIA PACIFIC CRO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.